West Pharmaceutical Services (NYSE:WST) unveiled two new wearable injectors today from its SmartDose drug delivery platform as part of the annual PDA Universe of Pre-filled Syringes and Injection Devices meeting in Vienna, Austria. West’s first-gen SmartDose device is a user-loaded injector designed to deliver high volumes of viscous drug products. Get the full story at our […]
At the 7th annual Partnership Opportunities in Drug Delivery event, presented by The Conference Forum, device companies gathered to tout their drug-delivery technologies and learn from each other’s mistakes and successes. Among them were needle-free injectors, patch pumps, auto-injectors and other novel delivery devices. Moderated by Pfizer‘s (NYSE:PFE) senior director of device strategy, Mathias Romacker, companies including Insulet (NSDQ:PODD), West Pharmaceutical […]
Shares in West Pharmaceutical Services (NYSE:WST) rose today after the company beat expectations on Wall Street with its third quarter results. The Exton, Penn.-based company posted profits of $51 million, or 69¢ per share, on sales of $398.2 million for the 3 months ended Sept. 30, for bottom-line growth of 36% on sales growth of 6% compared […]
If you’ve ever received a flu shot or taken insulin, you’ve probably used a device designed by West Pharmaceutical Services (NYSE:WST), according to VP & GM of biologics Graham Reynolds. “Probably most people have come in contact with West and they wouldn’t even know it,” he told Drug Delivery Business News. Over the 40 years he’s been with […]
West Pharmaceutical Services (NYSE:WST) touted results today from a study showing that its ID Adapter can improve the intradermal administration of polio vaccines. The study, published in the journal Vaccine, evaluated the feasibility of using a fractional inactivated polio virus vaccine in remote locations where polio outbreaks continue to be of serious concern to public health officials. […]
Shares in West Pharmaceutical (NYSE:WST) fell today after the manufacturer missed sales estimates on Wall Street with its second quarter results. The Exton, Penn.-based company posted profits of $38.8 million, or 51¢ per share, on sales of $397.6 million for the 3 months ended June 30, for bottom-line loss of -13% on sales growth of 2.5% compared […]
West Pharmaceutical Services is betting that an embrace of human factors engineering and experiential design will allow its drug delivery devices such as its SmartDose and SelfDose to stand apart from the crowd. People are more likely to take their medications properly if a device is easy to use, Eric Resnick, vice president and chief […]
West Pharmaceutical Services (NYSE:WST) said today that it finished a 60,000 square foot expansion of its contract manufacturing facility near Mulhuddart, County Dublin in Ireland. The expansion is a response to customer demand for medical device manufacturing, especially in the area of diabetes, the company reported. West anticipates 100 new jobs will be added to […]
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]
Amgen (NSDQ:AMGN) is partnering with West Pharmaceutical Services to integrate its SmartDose delivery platform into its Pushtronex system, the companies said today. The SmartDose technology is designed to adhere to a patient’s body, generally on the abdomen, and requires no patient operation during administration, the companies said. The technology includes integrated silicone-free Daikyo Crystal Zeniths’s cartridge […]
BG Medicine Inc. (NSDQ:BGMD) inked another deal to develop a version of its galectin-3 test for heart failure, this time with Health Diagnostics Laboratory Inc.
The diagnostic test screens for the presence of a protein called galectin-3, which is both a predictor and the cause of a certain type of heart failure.